Header cover image

Belgian Pharmaceuticals & Biotech Established, Profitable and Undervalued

UPDATED Aug 11, 2022

Over $1bn in market cap, profitable and undervalued based on cash flows.

1 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
UCBUCB€73.14-0.8%-25.5%€13.9b€102.71PE15.7xE20.2%1.8%
Page 1 of 1